The prescription-only S4
drug Clenbuterol, used as a
bronchodilator in horses and
by athletes as a performance
enhancer, is increasingly being used
by the general public.
A study published in the Medical
Journal of Australia found 63
cases of clenbuterol exposures
over nine years of data from the
NSW Poisons Information Centre,
with a “dramatic increase” from
three cases in 2008 to 27 in 2012,
with 84% of patients requiring
hospitalisation.
Researcher Dr Jonathan Brett said
there were arguments to restrict
sales by puting the drug into the
same category as benzodiazepines
and anabolic steroids.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 14
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.